Trial Profile
Clinical Evaluation of Condrosulf [chondroitin sulfate] 800 mg in the Treatment of Symptomatic OA [osteoarthritis] of the Hand: a 6-Month, Double-Blind, Placebo Controlled Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Chondroitin sulfate (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors IBSA
- 13 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Aug 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 23 Jun 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.